




















































Compounded medications are prepared by licensed pharmacies to meet the specific needs of individual patients. These medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. However, they are made in accordance with strict regulatory guidelines. If your clinician determines that a compounded medication is clinically appropriate for you, please be aware that it is not an FDA-approved product.
Ozempic®, Wegovy®, and Rybelsus® are the only FDA-approved products containing semaglutide produced by Novo Nordisk, Inc., while Zepbound® and Mounjaro® are the only FDA-approved products containing tirzepatide produced by Lilly USA LLC.
The Shed Guarantee is subject to eligibility and program requirements, including required check-ins and adherence to your treatment plan. See full terms and conditions.
Compounded medications are not FDA-approved and are prepared by a licensed pharmacy based on a provider's prescription. A prescription is only issued after a consultationwith a licensed provider who determines whether treatment is appropriate. Results may vary. Please refer to the Terms and Conditions for full details on the Shed weight-lossguarantee. In clinical trials of Wegovy® (2.4 mg), average weight loss was 15% and 20% when paired with diet and exercise.